Gavin Giovannoni

Professor of Neurology

Queen Mary University of London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Gavin Giovannoni is a Professor of Neurology at Queen Mary University of London, UK. His research focuses on the role of Epstein-Barr virus in multiple sclerosis, exploring areas such as immune modulation, therapeutic insights, and advanced treatment monitoring methodologies. Dr. Giovannoni's recent publications examine the implications of viral infections on disease progression and the development of patient-centered communication tools in multiple sclerosis care.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (4)

Jürg Kesselring

Senior Ambassador, former Head of Department

SWITZERLAND

View details

dawn langdon

Professor of Neuropsychology

Royal Holloway, University of London

UNITED KINGDOM

View details

Rena Patel

The University of Alabama

UNITED STATES

View details

Amanda Brumwell

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gavin Giovannoni

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

The path to prevention of multiple sclerosis: Considerations for Epstein-Barr virus vaccine-based prevention studies

Epstein-Barr Virus and spontaneous lymphoblastoid cell lines: establishment, molecular characteristics, immune modulation, and therapeutic insight

The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis

EBV-specific T-cell responses are telling us something important about multiple sclerosis

MRI versus relapse: optimal activity monitoring for management of progressive multiple sclerosis

Pharmacokinetics and Pharmacodynamics of Natalizumab 6-Week Dosing vs Continued 4-Week Dosing for Relapsing-Remitting Multiple Sclerosis

Making Information About Cladribine Tablets Accessible to People with Multiple Sclerosis: A Patient-Survey-Led Narrative Review for Healthcare Professionals

Summary of Research: Collaboration Between Healthcare Professionals and People with Multiple Sclerosis to Develop Communication Tools to Improve the Standard of Multiple Sclerosis Care

Is it ethical to use teriflunomide as an active comparator in phase 3 trials?

Revealing the immune cell subtype reconstitution profile in patients from the CLARITY study using deconvolution algorithms after cladribine tablets treatment

Collaborators (4)

Jürg Kesselring

dawn langdon

Rena Patel

Amanda Brumwell

Make your next move.